Literature DB >> 22244079

Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease.

R E Marx1, R Tursun.   

Abstract

Statistically, significant numbers of central bone specimens of suppurative osteomyelitis of the jaws (SOJ), bisphosphonate induced osteonecrosis of the jaws (BIONJ), and osteoradionecrosis of the jaws (ORNJ) were compared. All three evidenced the common finding of necrotic bone with empty osteocytic lacunae, Haversian and Volkmann canals, but each showed a distinctive histopathologic pattern indicating a different disease mechanism and treatment options. Suppurative osteomyelitis was characterized by intense marrow inflammation and marrow vessel thrombosis with retention of viable osteoclasts and periosteum. Bisphosphonate induced osteonecrosis was characterized by an empty marrow space with empty Howship's lacunae and an absence of osteoclasts but viable periosteum. Osteoradionecrosis was characterized by a collagenous hypocellular, hypovascular marrow space and nonviable periosteum. Histologic evidence in SOJ indicates a microorganism provoked intense inflammation and marrow vascular thrombosis creating an environment conducive to continual bacterial proliferation. BIONJ is seen as a non-inflammatory drug toxicity to bone by osteoclastic death leading to over suppression of bone renewal, and ORN as another non-inflammatory condition caused by a high linear energy transfer that impairs or kills numerous cell types in the field of radiation including periosteum, bone, and all soft tissue. Copyright Â
© 2011 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22244079     DOI: 10.1016/j.ijom.2011.12.016

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  33 in total

Review 1.  Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies.

Authors:  Si-Huei Lee; Rai-Chi Chan; Shy-Shin Chang; Yin-Ling Tan; Kai-Hsiang Chang; Matthew C Lee; Huai-En Chang; Chien-Chang Lee
Journal:  Support Care Cancer       Date:  2013-11-08       Impact factor: 3.603

2.  Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases.

Authors:  Sebastian Hoefert; Inge Schmitz; Frank Weichert; Marcel Gaspar; Harald Eufinger
Journal:  Clin Oral Investig       Date:  2014-06-24       Impact factor: 3.573

Review 3.  Osteochemonecrosis: an overview.

Authors:  John Hellstein
Journal:  Head Neck Pathol       Date:  2014-11-20

Review 4.  Osteoradionecrosis of the mandible: a review.

Authors:  Pravin N Lambade; Dipti Lambade; Manu Goel
Journal:  Oral Maxillofac Surg       Date:  2012-09-28

5.  Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.

Authors:  Masaya Akashi; Satoshi Wanifuchi; Eiji Iwata; Daisuke Takeda; Junya Kusumoto; Shungo Furudoi; Takahide Komori
Journal:  Oral Maxillofac Surg       Date:  2017-12-09

6.  Stage 0 osteonecrosis of the jaw in a patient on denosumab.

Authors:  Tara L Aghaloo; Sarah M Dry; Sanjay Mallya; Sotirios Tetradis
Journal:  J Oral Maxillofac Surg       Date:  2014-01-04       Impact factor: 1.895

7.  Combined Approach to Treat Medication-Related Osteonecrosis of the Jaws.

Authors:  Elisabetta Merigo; Luigi Cella; Aldo Oppici; Maria Cristina Arbasi; Fabio Clini; Matteo Fontana; Carlo Fornaini
Journal:  J Lasers Med Sci       Date:  2018-03-20

8.  Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw.

Authors:  Paul C Mathai; Neelam N Andrade; Neha Aggarwal; Shibani Nerurkar; Prathmesh Kapoor
Journal:  Oral Maxillofac Surg       Date:  2018-03-05

9.  Osteo-radio-necrosis (ORN) and bisphosphonate-related osteonecrosis of the jaws (BRONJ): the histopathological differences under the clinical similarities.

Authors:  Konstantinos T Mitsimponas; Patrick Moebius; Kerstin Amann; Philipp Stockmann; Karl-Andreas Schlegel; Friedrich-Wilhelm Neukam; Falk Wehrhan
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

10.  Osteonecrosis of the mandible due to anti-angiogenic agent, bevacizumab.

Authors:  Daria Pakosch; Dimitrios Papadimas; Johanna Munding; Darafsch Kawa; Marcus Stephan Kriwalsky
Journal:  Oral Maxillofac Surg       Date:  2012-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.